Clinical investigation of treatment with Qinghuang powder for 86 patients with chronic myelogenous leukemia
10.3760/cma.j.issn.1009-9921.2010.11.004
- VernacularTitle:青黄散治疗86例慢性粒细胞白血病临床观察
- Author:
Aixiang ZHOU
;
Zhiwei CHENG
;
Rou MA
;
Chengshan DENG
;
Feng LIU
;
Xiaomei HU
;
Naiping HU
- Publication Type:Journal Article
- Keywords:
Leukemia,myeloid,chronic;
Drug,chinese herbal;
Qinghuang powder
- From:
Journal of Leukemia & Lymphoma
2010;19(11):655-657
- CountryChina
- Language:Chinese
-
Abstract:
Objective To verify the clinical effect of Qinghuang powder in chronic myelogenous leukemia(CML). Methods 86 CML patients treated with Qinghuang powder, in which 28 cases also partially received herbal medicine (activating blood circulation to dissipate blood stasis). Results 62 cases had complete remission (72.1%), 14 cases partial remission (16.3 %), advance 8 cases(9.3 %), inefficiency 2 cases (2.3 %), and the total efficiency was 97.7 %. The symptom were improved after a week when patients had taken medicines. 44 cases have hepatomegalia, among them 39 cases have diminished or became normal compared to untreated. 70 cases have splenoparectasis, among them 60 cases became normal, 9 cases diminished, and 1 case had no change after treatment. It took 15.5 days in average when spleen began to diminish, and took 62.9 days to become smallest. The WBC began to decrease at 10.4 day and took 54.8 days in average became normal. The major side effect was digestive tract symptom, followed by skin pigmentation and skin excessive cornification. It could be avoided by low dosage. Conclusion Qinghuang powder could not only induce CML to CR, but also improve the clinical symptom of CML and eliminate the infiltration of leukemia cells. It has little influence to Hb and Plt.
